Eli Lilly launches weight-loss drug Mounjaro in India, beats Novo Nordisk to major market
Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...
Eli Lilly (LLY) Leads India’s Weight-Loss Drug Race with Mounjaro
Eli Lilly (LLY) has launched its weight-loss and diabetes drug, Mounjaro (tirzepatide), in India, securing a first-mover ...
Devdiscourse5d
Eli Lilly Launches Innovative Drug 'Mounjaro' to Combat Obesity and Diabetes in India
Eli Lilly and Company (India) has launched 'Mounjaro,' a novel medication for obesity and type 2 diabetes, after receiving ...
Devdiscourse4d
Eli Lilly Launches Mounjaro in India: A New Hope for Diabetes and Obesity
Eli Lilly has launched its diabetes and weight-loss drug Mounjaro in India, marking its entry into a rapidly growing market.
Why cheaper alternatives to weight-loss drugs like Wegovy, Zepbound will be tougher to get
The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...
Reuters16d
Eli Lilly plans to launch weight-loss drug in emerging markets this year
March 10 (Reuters) - Eli Lilly (LLY.N), opens new tab ... In February last year, CEO David Ricks told Reuters that Lilly expects to launch Mounjaro in India as early as 2025.
Eli Lilly launches weight-loss drug Mounjaro in India, Reuters says
Eli Lilly (LLY) launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk (NVO) for a ...
New York Post27d
Eli Lilly plans to invest $27B to build four new US plants as tariffs loom
including the popular weight-loss drug Mounjaro. Eli Lilly said the investment will create 3,000 high-skilled positions and approximately 10,000 construction jobs. Eli Lilly has unveiled plans to ...